ORIGINAL RESEARCH article
Front. Oncol.
Sec. Pediatric Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1672757
Surgical Management and Outcome of Medulloblastoma Patients at Addis Ababa between 2010 and 2018
Provisionally accepted
- 1Neurosurgery Unit, Department of Surgery, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
- 2Addis Ababa University School of Medicine, Addis Ababa, Ethiopia
- 3Hospital for Sick Children, University of Toronto, Toronto, Canada
- 4The Hospital for Sick Children, University of Toronto, Toronto, Canada
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Medulloblastoma is the most common malignant central nervous system tumor in pediatric patients and is relatively rare in adults. Despite remarkable improvement in survival over recent decades, the high success rates in management documented in the Western world are not mirrored in middle-and low-income countries, due to various socio-economic factors and health-care disparities. Objective: The aim of this study was to assess surgical treatment outcome and prognostic factors in operated patients with medulloblastoma in Tikur Anbessa Specialized Hospital and Myungsung Christian Medical Center, the 2 largest neurosurgical units in Ethiopia. Methods: This retrospective study involved 27 patients (21 children and 6 adolescent or young adults) who underwent surgery for medulloblastoma between January 2010 and April 2018. A structured questionnaire was used to collect patients' data and their treatment outcomes. 2 Results: the 6 months and 1-year overall survival (OS) were 41 % and 29% respectively, with a median survival time of 107 days (95% CI: 49,166). Median OS was 66 days (95% CI: 27,105), with 6 months and one-year OS rate of 24 % for pediatric patients. Younger age at presentation, postoperative open EVD, longer Intensive Care Unit stay, lack of radiation treatment & postoperative complications were negative predictors of outcome. Conclusion: This experience underscores the high number of undiagnosed patients with medulloblastoma in Ethiopia and the poor outcome of patients who undergo active treatment. Standardization of treatment with surgery, craniospinal irradiation ± chemotherapy yields longer survival rates in both pediatric and adult patients.
Keywords: Medulloblastoma, Surgery, Morbidity, Postoperative Complications, Low-Income Country
Received: 24 Jul 2025; Accepted: 15 Oct 2025.
Copyright: © 2025 Akililu, Bouffet and Abebe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yemisirach Bizuneh Akililu, yemisirachbizuneh@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.